Literature DB >> 7967436

[Venous thrombosis of cranial sinuses in asparaginase therapy. A case report].

U Schulz1, G Mann, A Zoubek, H Gadner.   

Abstract

Changes in the coagulation system due to steroids and asparaginase during treatment for acute lymphoblastic leukemia (ALL) are well known side effects and may cause bleeding or thrombosis. We report the case history of a 7-year old girl who developed thrombosis of the sinus sagittalis superior during ALL-treatment. Diagnosis was made by computed tomography and magnetic resonance imaging after the child became symptomatic with seizure. Until this event the girl had been treated already for two weeks with prednisone and E. coli-asparaginase (4 infusions). This medication caused distinct hypofibrinogenemia (Fibrinogen 53 mg/dl), prothrombin time expressed as percent of normal values of 58% was also pathological, activated partial thromboplastin time of 35 sec, antithrombin III 120% and thrombocyte count 178 G/l were in normal range. We were not successful in the attempt to adjust the imbalance in the coagulation system by transfusion of fresh frozen plasma (FFP)--seizure happened during FFP-infusion, fibrinogen blood level could be elevated only slightly. Our patient stayed consequently asymptomatic, the clinical recovery was confirmed radiologically.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7967436     DOI: 10.1055/s-2008-1046627

Source DB:  PubMed          Journal:  Klin Padiatr        ISSN: 0300-8630            Impact factor:   1.349


  2 in total

Review 1.  Magnetic resonance imaging patterns of treatment-related toxicity in the pediatric brain: an update and review of the literature.

Authors:  Maria Camilla Rossi Espagnet; Luca Pasquini; Antonio Napolitano; Antonella Cacchione; Angela Mastronuzzi; Roberta Caruso; Paolo Tomà; Daniela Longo
Journal:  Pediatr Radiol       Date:  2016-12-09

2.  Sagittal sinus thrombosis due to L-asparaginase.

Authors:  Nisar A Wani; Tasleem Kosar; Nazir A Pala; Umar A Qureshi
Journal:  J Pediatr Neurosci       Date:  2010-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.